Skin Pharmacology and Physiology
Research Article
In vivo Human Skin Penetration of the UV Filter Ethylhexyl Triazone: Effect of Lipid Microparticle EncapsulationScalia S. · Battaglioli S. · Bianchi A.Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: July 24, 2018
Accepted: September 13, 2018
Published online: October 31, 2018
Issue release date: December 2018
Number of Print Pages: 10
Number of Figures: 5
Number of Tables: 3
ISSN: 1660-5527 (Print)
eISSN: 1660-5535 (Online)
For additional information: https://www.karger.com/SPP
Abstract
Background/Aims: The data available on the skin permeability of ethylhexyl triazone (EHT), a widely used high-molecular-weight (823.1-Da) UV filter, are scarce and obtained only via in vitro studies. Therefore, we evaluated in vivo the penetration of EHT in human stratum corneum by the tape stripping technique. Moreover, the effect of EHT encapsulation in lipid microparticles (LMs) on its diffusion through the stratum corneum was examined. Methods: LMs loaded with EHT were prepared using glyceryl behenate and phosphatidylcholine. Creams containing EHT free or encapsulated in LMs in conjunction with the two most commonly used UV filters, octyl methoxycinnamate (OMC) and butyl methoxydibenzoylmethane (BMDBM), were applied to human volunteers and the fraction of the applied sunscreen dose having penetrated into different stratum corneum layers was measured. Results and Conclusion: For the cream with the nonencapsulated sunscreen agent, the percentage of the applied EHT dose diffused into the stratum corneum was 21.9 ± 4.9%, not significantly different from that of the smaller-molecular-weight OMC (22.2 ± 7.6%) and BMDBM (20.5 ± 3.7%). A marked (45.7%) and statistically significant reduction in the in vivo skin penetration of EHT was attained with the cream containing microencapsulated EHT. The decreased percutaneous penetration provided by the LMs should favor the efficacy of EHT and limit potential toxicological risks.
© 2018 S. Karger AG, Basel
Related Articles:
References
- Lautenschlager S, Wulf HC, Pittelkow MR. Photoprotection. Lancet. 2007 Aug;370(9586):528–37.
-
European Union. Commission recommendation 2006/647/EC on the efficacy of sunscreen products and the claims made relating thereto. Official J Eur Union. 2006;L 265/39.
- Hojerová J, Peráčková Z, Beránková M. Margin of safety for two UV filters estimated by in vitro permeation studies mimicking consumer habits: effects of skin shaving and sunscreen reapplication. Food Chem Toxicol. 2017 May;103:66–78.
- Puglia C, Damiani E, Offerta A, Rizza L, Tirendi GG, Tarico MS, et al. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies. Eur J Pharm Sci. 2014 Jan;51:211–7.
- Hojerová J, Medovcíková A, Mikula M. Photoprotective efficacy and photostability of fifteen sunscreen products having the same label SPF subjected to natural sunlight. Int J Pharm. 2011 Apr;408(1-2):27–38.
- Potard G, Laugel C, Schaefer H, Marty JP. The stripping technique: in vitro absorption and penetration of five UV filters on excised fresh human skin. Skin Pharmacol Appl Skin Physiol. 2000 Nov-Dec;13(6):336–44.
- Chatelain E, Gabard B, Surber C. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol Appl Skin Physiol. 2003 Jan-Feb;16(1):28–35.
- Scalia S, Mezzena M, Ramaccini D. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. Skin Pharmacol Physiol. 2011;24(4):182–9.
- Freitas JV, Praça FS, Bentley MV, Gaspar LR. Trans-resveratrol and beta-carotene from sunscreens penetrate viable skin layers and reduce cutaneous penetration of UV-filters. Int J Pharm. 2015 Apr;484(1-2):131–7.
- Souza C, Maia Campos PM. Development of a HPLC method for determination of four UV filters in sunscreen and its application to skin penetration studies. Biomed Chromatogr. 2017 Dec;31(12):e4029.
- Nash JF, Tanner PR. Relevance of UV filter/sunscreen product photostability to human safety. Photodermatol Photoimmunol Photomed. 2014 Apr-Jun;30(2-3):88–95.
- Hagedorn-Leweke U, Lippold BC. Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes. Pharm Res. 1995 Sep;12(9):1354–60.
- Simeoni S, Scalia S, Benson HA. Influence of cyclodextrins on in vitro human skin absorption of the sunscreen, butyl-methoxydibenzoylmethane. Int J Pharm. 2004 Aug;280(1-2):163–71.
- Golmohammadzadeh S, Jaafarixx MR, Khalili N. Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method. J Cosmet Sci. 2008 Sep-Oct;59(5):385–98.
-
Herzog B, Hueglin D, Osterwalder U. New sunscreens actives. In: Shaath N, editor. Sunscreens. Boca Raton: Taylor Francis Group; 2005. p. 293.
-
Shi L, Shan J, Ju Y, Aikens P, Prud’homme RK. Nanoparticles as delivery vehicles for sunscreen agents. Colloids Surf A Physicochem Eng Asp. 2012 Feb;396:122–9.
External Resources
- Herzog B, Wehrle M, Quass K. Photostability of UV absorber systems in sunscreens. Photochem Photobiol. 2009 Jul-Aug;85(4):869–78.
- Lhiaubet-Vallet V, Marin M, Jimenez O, Gorchs O, Trullas C, Miranda MA. Filter-filter interactions. Photostabilization, triplet quenching and reactivity with singlet oxygen. Photochem Photobiol Sci. 2010 Apr;9(4):552–8.
- Monti D, Brini I, Tampucci S, Chetoni P, Burgalassi S, Paganuzzi D, et al. Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin. Skin Pharmacol Physiol. 2008;21(6):318–25.
- Menon GK. New insights into skin structure: scratching the surface. Adv Drug Deliv Rev. 2002 Nov;54 Suppl 1:S3–17.
- Lademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm. 2009 Jun;72(2):317–23.
- Jaspart S, Piel G, Delattre L, Evrard B. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv. 2005 Jan;2(1):75–87.
- Scalia S, Young PM, Traini D. Solid lipid microparticles as an approach to drug delivery. Expert Opin Drug Deliv. 2015 Apr;12(4):583–99.
- Simeoni S, Tursilli R, Bianchi A, Scalia S. Assay of common sunscreen agents in suncare products by high-performance liquid chromatography on a cyanopropyl-bonded silica column. J Pharm Biomed Anal. 2005 Jun;38(2):250–5.
- Scalia S, Trotta V, Iannuccelli V, Bianchi A. Enhancement of in vivo human skin penetration of resveratrol by chitosan-coated lipid microparticles. Colloids Surf B Biointerfaces. 2015 Nov;135:42–9.
- Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm. 2008 Jun;357(1-2):295–304.
-
ISO 24443:2012. Determination of sunscreen UVA photoprotection in vitro. Geneva: ISO; 2012.
-
Diffey BL, Robson J. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem. 1989;40:127–33.
- Yue Y, Zhou H, Liu G, Li Y, Yan Z, Duan M. The advantages of a novel CoQ10 delivery system in skin photo-protection. Int J Pharm. 2010 Jun;392(1-2):57–63.
- Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004 Jul;123(1):168–76.
- Milak S, Medlicott N, Tucker IG. Solid lipid microparticles containing loratadine prepared using a Micromixer. J Microencapsul. 2006 Dec;23(8):823–31.
-
Klein K, Palefsky I. Formulating sunscreen products. In: Shaath N, editor. Sunscreens. Boca Raton: Taylor Francis Group; 2005. p. 356.
-
Bonda CA. The photostability of organic sunscreen actives: a review. In Shaath N, editor. Sunscreens. Boca Raton: Taylor Francis Group; 2005. p. 323–34.
- Hanno I, Anselmi C, Bouchemal K. Polyamide nanocapsules and nano-emulsions containing Parsol® MCX and Parsol® 1789: in vitro release, ex vivo skin penetration and photo-stability studies. Pharm Res. 2012 Feb;29(2):559–73.
-
Organisation for Economic Cooperation and Development. Guidelines for Testing of Chemicals, Guideline 428: Skin Absorption – In vitro Method. Paris: OECD; 2004.
- Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, et al. Bioequivalence of topical dermatological dosage forms – methods of evaluation of bioequivalence. Pharm Res. 1998 Feb;15(2):167–71.
- Weigmann HJ, Lademann J, Schanzer S, Lindemann U, von Pelchrzim R, Schaefer H, et al. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:98–102.
- Ferrero L, Pissavini M, Marguerie S, Zastrow L. Sunscreen in vitro spectroscopy: application to UVA protection assessment and correlation with in vivo persistent pigment darkening. Int J Cosmet Sci. 2002 Apr;24(2):63–70.
- Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007;20(1):10–20.
- Sommer S, Wilkinson SM, English JS, Ferguson J. Photoallergic contact dermatitis from the sunscreen octyl triazone. Contact Dermat. 2002 May;46(5):304–5.
Article / Publication Details
Received: July 24, 2018
Accepted: September 13, 2018
Published online: October 31, 2018
Issue release date: December 2018
Number of Print Pages: 10
Number of Figures: 5
Number of Tables: 3
ISSN: 1660-5527 (Print)
eISSN: 1660-5535 (Online)
For additional information: https://www.karger.com/SPP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission